Cancer immunotherapy in routine cost-effective cancer care?

被引：2
|
作者：
Feldmann, Sir Marc [1 ]
机构：
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
来源：
EMBO MOLECULAR MEDICINE | 2018年 / 10卷 / 11期
关键词：
ANTIBODY;
D O I：
10.15252/emmm.201809660
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Therapy-triggered autoimmunity and inflammation in many cancer patients, as well as treatment costs, hamper the success of cancer immunotherapy. The study by Pfeiffer et al in this issue of EMBO Molecular Medicine constitutes a clear step towards a more simple, scalable and affordable approach in generating in situ T cells reprogrammed with chimeric antigen receptors (CARs) (Pfeiffer et al, ).
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Is population screening for colorectal cancer cost-effective?
    Pignone, M
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (07): : 288 - 289
  • [22] Screening for lung cancer: Can it be cost-effective?
    Miettinen, OS
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (10) : 1431 - 1436
  • [23] Tele Oncology Clinics in Rural Australia: a Cost-effective Cancer Care Model
    Thaker, D. A.
    Sabesan, S. S.
    Van Houts, B.
    Bryett, A.
    Olver, I. N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S213 - S214
  • [24] IS SCREENING FOR BREAST-CANCER COST-EFFECTIVE
    MUSHLIN, AI
    FINTOR, L
    CANCER, 1992, 69 (07) : 1957 - 1962
  • [25] Surveillance following breast cancer: is it cost-effective?
    Ternent, L.
    MacLennan, G.
    Heys, S. D.
    Gilbert, F.
    Vale, L.
    BREAST CANCER RESEARCH, 2010, 12
  • [26] Surveillance following breast cancer: is it cost-effective?
    L Ternent
    G MacLennan
    SD Heys
    F Gilbert
    L Vale
    Breast Cancer Research, 12
  • [27] Cost-effective tests prescription for early detection of cancer in the Hellenic primary care
    Kamposioras, Konstantinos
    Mauri, Davide
    Neanidis, Konstantinos
    Alexiou, George
    Polyzos, Nikolaos P.
    Vittoraki, Angeliki
    Briastianou, Magdalini
    Timotheadou, Eleni
    Fountzilas, George
    Milousis, Athanasios
    ANNALS OF ONCOLOGY, 2006, 17 : 278 - 278
  • [28] WHEN IS CANCER CARE COST-EFFECTIVE? A SYSTEMATIC OVERVIEW OF COST-UTILITY ANALYSES IN ONCOLOGY
    Greenberg, D.
    Earle, C.
    Fang, C.
    Eldar-Lissai, A.
    Neumann, P. J.
    VALUE IN HEALTH, 2009, 12 (03) : A2 - A2
  • [29] When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology
    Greenberg, Dan
    Earle, Craig
    Fang, Chi-Hui
    Eldar-Lissai, Adi
    Neumann, Peter J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02): : 82 - 88
  • [30] To screen or not to screen? Is it worth it for oral cancer?: Is a primary care screening programme for oral cancer cost-effective?
    Conway D.I.
    Speight P.M.
    Palmer S.
    Moles D.R.
    Evidence-Based Dentistry, 2006, 7 (3) : 81 - 82
12345